Partner with Us

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio and/or its proprietary UbiPro™ Drug Discovery Platform. We have used novel approaches to therapeutic intervention targeting the ubiquitin pathway and our key discoveries are creating new opportunities for ameliorating disease. Progenra’s unsurpassed know-how, assay technology, diverse chemical library and genuine devotion are paving the way for a new class of drug.

BD Figure 2016